COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Health care providers should stop using N95 respirators made by Shanghai Dasheng Health Products Manufacturing Co. Ltd., which are no longer authorized for emergency use, the Food and Drug Administration announced.
The Centers for Disease Control and Prevention released research highlighting two important trends emerging from the COVID-19 pandemic regarding vaccines’ current effectiveness.
The Food and Drug Administration today granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over. The vaccine, which will now be marketed as Comirnaty, is the first COVID-19 vaccine to go beyond emergency use status in the United States.
The Centers for Medicare & Medicaid Services issued a Health Plan Management System memo to all Medicare Advantage Organizations and Medicare-Medicaid Plans to strongly encourage them to waive or relax plan prior authorization requirements and utilization management processes to facilitate the…
In evaluating whether to temporarily suspend survey activities if a hospital experiences a COVID-19 surge, the Centers for Medicare & Medicaid Services in June told AHA it will consider whether the hospital has notified the appropriate state public health agency and activated its emergency…
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., authorized a third, additional dose of the mRNA COVID-19 vaccines for people with moderately to severely compromised immune systems. This includes people who have:
There’s a lot of misinformation about COVID-19 vaccines. Get the facts from the experts at the Centers for Disease Control and Prevention and the American Medical Association.
The Food and Drug Administration announced amendments of Pfizer and Moderna’s COVID-19 vaccine emergency use authorizations to allow for the use of a third, additional dose for certain immunocompromised individuals.
The Centers for Disease Control and Prevention released a study confirming the comparative effectiveness of COVID-19 vaccines versus natural immunity, including immunity gained from prior SARS-CoV-2 infection.
In evaluating whether to temporarily suspend survey activities if a hospital experiences a COVID-19 surge, CMS last month told AHA it will consider whether the hospital has notified the appropriate state public health agency and activated its emergency preparedness plan, and the proportion of…